Conference Coverage
Conference Coverage
Unsure on the best T2D drug choice? Let patients decide
Serially testing equally viable drug options for people with type 2 diabetes can identify the regimen that works best for each individual patient...
Conference Coverage
Early age at hysterectomy ups type 2 diabetes risk
Having a hysterectomy appears to increase the risk of incident type 2 diabetes, particularly in younger women, and if the ovaries are removed at...
Conference Coverage
Could cold exposure, especially shivering, combat type 2 diabetes?
"The results are highly promising and may eventually suggest an alternative treatment or preventative measure for type 2 diabetes."
Conference Coverage
Mothers’ diabetes linked to ADHD in their children
A small increased risk of ADHD in children born to mothers with diabetes, including pregestational diabetes and gestational diabetes, has been...
Conference Coverage
Triple threat: Novel agent shows potent T2D weight loss in phase 1
A novel triple agonist targeting the GIP, GLP-1, and glucagon receptors produced unprecedented weight loss in patients with type 2 diabetes after...
Conference Coverage
‘Amazing’ data for cheap beta-blocker gel for diabetic foot ulcers
Esmolol, a widely available and cheap beta-blocker, shows statistically significant superiority over the standard of care for diabetic foot ulcers...
Conference Coverage
Eat more dairy, less red meat to prevent type 2 diabetes
Not all animal foods are alike when it comes to their association with type 2 diabetes risk, shows a large new review. The devil is in the details...
Conference Coverage
Whole grains may improve survival in people with type 2 diabetes
Fish, whole grain, fiber, and polyunsaturated fats are found to reduce premature death in a large overview of studies in people with type 2...
Conference Coverage
Waist-hip ratio beats BMI for predicting obesity’s mortality risk
Data from more than 380,000 people in the UK Biobank show waist-to-hip ratio estimated mortality risk from obesity better than BMI or fat mass...
Conference Coverage
‘Game changer’ semaglutide halves diabetes risk from obesity
Post-hoc analysis of two semaglutide trials in people with obesity showed treatment cut their projected 10-year risk for incident type 2 diabetes...